Rene Russo - Insider Trading & Ownership

Location
C/O Arsanis, Inc., 890 Winter Street, Suite 230, Waltham, MA
Summary
The estimated net worth of Rene Russo is at least $8.18M dollars as of June 18, 2025. Rene Russo is the Director of Adagio Therapeutics, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $7.84M. Rene Russo is the PRESIDENT AND CEO, Director of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $329K. Rene Russo is the Director of X4 Pharmaceuticals, Inc and owns shares of X4 Pharmaceuticals, Inc (XFOR) stock worth about $7.68K.
Signature
/s/ Kevin Brennan, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Rene Russo

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IVVD Invivyd, Inc. Director $7.84M Aug 5, 2021
XLO Xilio Therapeutics, Inc. PRESIDENT AND CEO, Director $329K +$24.7K +8.1% Jun 16, 2025
XFOR X4 Pharmaceuticals, Inc Director $7.68K Jun 2, 2021

Insider Transactions Reported by Rene Russo:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.